Expanse Bio LLC

North Charleston, SC

UEI
Q1RBL5JSKJ75
CAGE
9BF22
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
4401 Leeds Ave #130, North Charleston, SC 29405, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
EX vivo whole ovary culture system for screening gonadotoxicity during drug development R43HD114386 National Institute of Child Health and Human Development (NIH) $309,251
Fertility protection in cancer: recovery of whole ovaries enabled by next GEN perfusion, cryoprotection, and nanowarming R44CA228758 National Cancer Institute (NIH) $3,406,120
New approaches to kidney banking through nature-inspired high sub-zero preservation strategies R44DK117801 National Institute of Diabetes and Digestive and Kidney Diseases (NIH) $3,731,530
Neonatal and young pediatric kidney preservation through nanowarming and vitrification R44AI186974 National Institute of Allergy and Infectious Diseases (NIH) $3,973,900
Isochoric pressure based preservation of ovarian tissue R44HD089832 National Institute of Child Health and Human Development (NIH) $11,650,958

Similar vendors

Vendor Location Primary NAICS
Tissue Testing Technologies LLC UEI ZSY2J1RRALT5 North Charleston, SC 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sylvatica Biotech Inc. UEI FJJVUJGDDLS3 North Charleston, SC 541714 Research and Development in Biotechnology (except Nanobiotechnology)
X-Therma Inc. UEI MKP9GFAJNEY9 Hercules, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Plurexa LLC UEI WAV2HG8VLNK4 Seattle, WA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Functional Circulation LLC UEI CWV6RGWLDVD3 Lake Mills, WI 339112 Surgical and Medical Instrument Manufacturing

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Expanse Bio LLC is a partnership or limited liability company that registered with SAM.gov on June 15, 2022 with a for-profit and limited liability company business structure. It performs biomedical research and develops biotechnology products related to organ preservation and fertility preservation.

Expanse Bio LLC has received several project grant awards from federal agencies like the National Institutes of Health (NIH) to fund its biomedical research initiatives. One award from the National Institute of Child Health and Human Development supported the development of an ex vivo microfluidic organ perfusion device for long-term culture and assessment of whole ovaries, aiming to provide a more physiologically relevant model for evaluating ovotoxicity of drug candidates. Another award from the National Cancer Institute funded research on fertility protection in cancer patients by enabling recovery of whole ovaries through next-generation perfusion, cryoprotection, and nanowarming techniques. Additionally, Expanse Bio LLC received an award from the National Institute of Diabetes and Digestive and Kidney Diseases to develop a nature-inspired, machine perfusion-enabled, subzero solution for dramatically extending preservation times of human and porcine kidneys. This involved strategies like multi-temperature multi-step machine perfusion, cryostasis cocktail formulation, and validation through porcine model kidney transplantation and human kidney assessment trials.

Quick answers

Is Expanse Bio LLC registered in SAM.gov?

Yes. Expanse Bio LLC's SAM.gov registration is active through July 16, 2027.

What is Expanse Bio LLC's most recent federal award?

Expanse Bio LLC's most recent federal grant award is EX vivo whole ovary culture system for screening gonadotoxicity during drug development (R43HD114386), from National Institute of Child Health and Human Development (NIH), on September 22, 2023.

On GovTribe

See Expanse Bio LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login